17.75 USD
▲+0.25+1.43%
盘后 17.21 -3.04%
2026-09-18
市值
$1.10B
市盈率
—
EPS
-4.25
股息率
—
52 周区间
4.30 – 49.97
成交量
3.97M
Beta
2.60
目标价
42.50
52W 低 4.3052W 高 49.97
价格走势
公司简介
Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-approved small-molecule drugs and is advancing tumor-infiltrating lymphocyte (TIL) cell therapies that le...